News
BIVIW
0.4400
+2.33%
0.0100
BIOVIE - FILES TO OFFER UP TO $300 MLN IN SECURITIES - SEC FILING
Reuters · 06/18 21:22
BioVie posts corporate presentation spotlighting bezisterim longevity-focused therapy pipeline
PUBT · 06/02 14:20
BioVie to host live investor webinar with CEO presentation and Q&A
PUBT · 05/27 12:03
BioVie completes enrollment in Phase 2 long COVID trial of bezisterim, targets late summer 2026 data
PUBT · 05/26 12:06
BIOVIE ANNOUNCES FULL ENROLLMENT OF THE ADDRESS-LC TRIAL OF BEZISTERIM FOR THE TREATMENT OF NEUROLOGICAL SYMPTOMS ASSOCIATED WITH LONG COVID
Reuters · 05/26 12:00
BioVie completes Phase 2 SUNRISE-PD trial of bezisterim in early Parkinson’s disease
PUBT · 05/18 12:04
BIOVIE ANNOUNCES COMPLETION OF PHASE 2 SUNRISE-PD TRIAL IN EARLY-STAGE PARKINSON’S DISEASE
Reuters · 05/18 12:00
BioVie Q3 FY26 net loss widens to $5.3 million; operating expenses climb to $5.4 million
PUBT · 05/11 20:57
BioVie SUNRISE-PD bezisterim abstract accepted for presentation at 2026 AAN meeting
PUBT · 04/14 12:05
BioVie publishes corporate presentation on bezisterim pipeline catalysts in Parkinson’s, Long Covid
Reuters · 04/01 22:27
BioVie to present SUNRISE-PD bezisterim poster at AD/PD 2026
Reuters · 03/12 12:05
BioVie to Host Live Investor Webinar and Q&A Session with CEO Cuong Do
Reuters · 02/23 13:04
BioVie Inc. Announces Phase 2 and 3 Clinical Trials of Bezisterim for Alzheimer's and Long COVID
Reuters · 02/12 13:01
OPTION THERAPEUTICS INC SAYS THINKEQUITY IS THE UNDERWRITER TO IPO
Reuters · 01/26 11:03
BioVie Inc. unveils new data on bezisterim's potential in Parkinson's and Alzheimer's therapies
Reuters · 01/10 18:53
BioVie Completes Enrollment for Phase 2 SUNRISE-PD Trial Testing Bezisterim in Early Parkinson’s Disease
Reuters · 01/08 13:02
BIOVIE COMPLETES ENROLLMENT IN PHASE 2 SUNRISE-PD TRIAL IN EARLY PARKINSON’S DISEASE
Reuters · 01/08 13:00
BIOVIE INC - TOPLINE RESULTS FROM SUNRISE-PD TRIAL EXPECTED IN 1H 2026
Reuters · 01/08 13:00
Halozyme Therapeutics Elects Jim Lang to Board of Directors
Reuters · 12/08/2025 21:05
BioVie Inc. Files Initial Statement of Beneficial Ownership for Director Kameel D. Farag
Reuters · 10/28/2025 15:20
More
Webull provides a variety of real-time BIVIW stock news. You can receive the latest news about Biovie Inc through multiple platforms. This information may help you make smarter investment decisions.